169 related articles for article (PubMed ID: 67211)
1. Serologic identification of multiple tumor-associated antigens on murine sarcomas.
Parker GA; Rosenberg SA
J Natl Cancer Inst; 1977 May; 58(5):1303-9. PubMed ID: 67211
[TBL] [Abstract][Full Text] [Related]
2. Cross-reacting antigens in chemically induced sarcomas are fetal determinants.
Parker GA; Rosenberg SA
J Immunol; 1977 May; 118(5):1590-4. PubMed ID: 67142
[TBL] [Abstract][Full Text] [Related]
3. Serologic evidence for cross-reacting antigens in two carcinogen-induced murine sarcomas.
Fritze D; Kern DH; Waldman SR; Pilch YH
Int J Cancer; 1975 Jan; 15(1):116-31. PubMed ID: 1079201
[TBL] [Abstract][Full Text] [Related]
4. Cell-mediated reactivity to antigens shared by Moloney-virus-induced lymphomas (LSTRA) and certain 3-methylcholanthrene-induced mouse sarcomas.
Hellström I; Hellström KE; Zeidman L; Bernstein ID; Brown JP
Int J Cancer; 1979 Apr; 23(4):555-64. PubMed ID: 86527
[TBL] [Abstract][Full Text] [Related]
5. The serologic response to Meth A sarcoma vaccines after cyclophosphamide treatment is additionally increased by various adjuvants.
Livingston PO; Jones M; Deleo AB; Oettgen HF; Old LJ
J Immunol; 1985 Aug; 135(2):1505-9. PubMed ID: 4008930
[TBL] [Abstract][Full Text] [Related]
6. A microassay for humoral cytotoxicity demonstrating sublethal effects of antibody.
Cleveland PH; McKhann CF; Johnson K; Nelson S
Int J Cancer; 1974 Sep; 14(3):417-26. PubMed ID: 4459274
[No Abstract] [Full Text] [Related]
7. Comparative in vitro sensitivity of twom methylcholanthrene-induced murine sarcoma lines to humoral and cellular immune cytotoxicity.
Bataillon G; Pross H; Klein G
Int J Cancer; 1975 Aug; 16(2):255-65. PubMed ID: 1150353
[TBL] [Abstract][Full Text] [Related]
8. Cross-reacting tumor associated transplantation antigen on primary 3-methylcholanthrene-induced BALB/c sarcomas.
Coggin JH
Mol Biother; 1989; 1(4):223-8. PubMed ID: 2818874
[TBL] [Abstract][Full Text] [Related]
9. In vitro demonstration of cryosurgical augmentation of tumor immunity.
Faraci RP; Bagley DH; Marrone J; Beazley RM
Surgery; 1975 Mar; 77(3):433-8. PubMed ID: 1124499
[TBL] [Abstract][Full Text] [Related]
10. Alien H-2 allospecificities in murine chemically-induced tumors.
Merino F
Immunol Commun; 1979; 8(5-6):555-62. PubMed ID: 94037
[TBL] [Abstract][Full Text] [Related]
11. Serologically detectable specific and cross-reactive antigens on the membrane of a polyoma virus-induced murine tumor.
Witz IP; Lee N; Klein G
Int J Cancer; 1976 Aug; 18(2):243-9. PubMed ID: 60289
[TBL] [Abstract][Full Text] [Related]
12. Actinomycin-D-resistant in vitro mouse cell line derived from a methylcholanthrene-induced sarcoma: decrease of malignancy and antigenic characteristics.
Belehradek J; Biedler JL; Thonier M; Barski G
Int J Cancer; 1974 Dec; 14(6):779-88. PubMed ID: 4142788
[TBL] [Abstract][Full Text] [Related]
13. Serological analysis of BALB/C methylcholanthrene sarcoma Meth A by SEREX: identification of a cancer/testis antigen.
Ono T; Sato S; Kimura N; Tanaka M; Shibuya A; Old LJ; Nakayama E
Int J Cancer; 2000 Dec; 88(6):845-51. PubMed ID: 11093803
[TBL] [Abstract][Full Text] [Related]
14. Production of a tumor-specific xenoantiserum from partially purified immunoprotective tumor antigen.
Tanaka T; Yamagishi H; Pellis NR; Kahan BD
Cancer Immunol Immunother; 1982; 13(1):48-52. PubMed ID: 6760958
[TBL] [Abstract][Full Text] [Related]
15. Tumour-related antigen specificities associated with 3-methylcholanthrene-treated rat embryo cells.
Embleton MJ; Baldwin RW
Int J Cancer; 1979 Jun; 23(6):840-5. PubMed ID: 89103
[TBL] [Abstract][Full Text] [Related]
16. Quantitative detection of cytotoxic antibodies against tumor-specific antigens of murine sarcomas induced by 3-methylcholanthrene.
Bloom ET
J Natl Cancer Inst; 1970 Sep; 45(3):443-53. PubMed ID: 5523193
[No Abstract] [Full Text] [Related]
17. Micro mixed hemadsorption assay--a sensitive method for detecting antibodies against tumor-associated antigens.
Reddy AL; Hudes MI; Karp RD; Mullen Y
J Immunol Methods; 1977; 17(3-4):293-307. PubMed ID: 334993
[TBL] [Abstract][Full Text] [Related]
18. Tumor-derived autophagosome vaccine: induction of cross-protective immune responses against short-lived proteins through a p62-dependent mechanism.
Twitty CG; Jensen SM; Hu HM; Fox BA
Clin Cancer Res; 2011 Oct; 17(20):6467-81. PubMed ID: 21810919
[TBL] [Abstract][Full Text] [Related]
19. Phenotypes associated with tumor rejection mediated by cyclophosphamide and syngeneic tumor-sensitized T lymphocytes: potential mechanisms of action.
Evans R
Int J Cancer; 1984 Mar; 33(3):381-8. PubMed ID: 6607893
[TBL] [Abstract][Full Text] [Related]
20. Tumor-secific immunity to chemically induced tumors. Evidence for immunologic specificity and shared antigenicity in lymphocyte responses to soluble tumor antigens.
Frbes JT; Nakaw Y; Smith RT
J Exp Med; 1975 May; 141(5):1181-200. PubMed ID: 47896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
